Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 571 to 585 of 736 results for adult social

  1. What community-based interventions are effective and cost effective in improving dietary habits affecting the oral health of children and adults, and in particular those at high risk of poor oral health?

    effective in improving dietary habits affecting the oral health of children and adults, and in particular those at high risk of poor...

    Research recommendation
    Published
    9 June 2015

  2. What community-based interventions are effective and cost effective in improving oral health and reducing oral health inequalities among groups of adults at high risk of poor oral health?

    improving oral health and reducing oral health inequalities among groups of adults at high risk of poor oral health? Any explanatory...

    Research recommendation
    Published
    9 June 2015

  3. Mogamulizumab for previously treated T-cell leukaemia-lymphoma [ID1390]

    Discontinued Reference number: GID-TA10464

    Technology appraisal guidance
    Discontinued

  4. Use of hearing aids and incidence of dementia:- In adults with hearing loss, does the use of hearing aids reduce the incidence of dementia?

    NG98/3 Question Use of hearing aids and incidence of dementia:- In adults with hearing loss, does the use of hearing aids reduce the...

    Research recommendation
    Published
    10 December 2018

  5. Dupilumab for treating moderate to severe atopic dermatitis (TA534)

    Evidence-based recommendations on dupilumab (Dupixent) for treating moderate to severe atopic dermatitis in adults.

    Technology appraisal guidance
    Published
    1 August 2018
    View recommendations

    Sections for TA534

  6. Brodalumab for treating moderate to severe plaque psoriasis (TA511)

    Evidence-based recommendations on brodalumab (Kyntheum) for treating moderate to severe plaque psoriasis in adults.

    Technology appraisal guidance
    Published
    21 March 2018
    View recommendations

    Sections for TA511

  7. Psychological interventions for depression and anxiety disorders in adults with mild to moderate learning disabilities:- For adults with milder learning disabilities, what is the clinical and cost effectiveness of psychological interventions such as cognitive behavioural therapy (modified for people with learning disabilities) for treating depression and anxiety disorders?

    interventions for depression and anxiety disorders in adults with mild to moderate learning disabilities:- For adults with...

    Research recommendation
    Published
    17 October 2016

  8. Supporting people to plan for the future: What is the effectiveness and cost-effectiveness of early, preventative support for people with complex needs?

    Source guidance details Comes from guidance Social work with adults experiencing complex needs Number NG216 Date issued

    Research recommendation
    Published
    1 June 2022

  9. Pembrolizumab with pemetrexed and platinum chemotherapy for untreated, metastatic, non-squamous non-small-cell lung cancer (TA683)

    Evidence-based recommendations on pembrolizumab (Keytruda) with pemetrexed and platinum chemotherapy for untreated, metastatic, non-squamous non-small-cell lung cancer (NSCLC) in adults whose tumours have no epidermal growth factor receptor (EGFR)- or anaplastic lymphoma kinase (ALK)-positive mutations.

    Technology appraisal guidance
    Published
    10 March 2021
    View recommendations

    Sections for TA683

  10. Nivolumab for treating recurrent or metastatic squamous cell carcinoma of the head and neck after platinum-based chemotherapy (TA736)

    Evidence-based recommendations on nivolumab (Opdivo) for treating recurrent or metastatic squamous cell carcinoma of the head and neck after platinum-based chemotherapy in adults.

    Technology appraisal guidance
    Published
    20 October 2021
    View recommendations

    Sections for TA736

  11. Decision-making:- What interventions, systems and processes are effective and cost effective in changing health and social care practitioners' decision-making and ensuring appropriate antimicrobial stewardship?

    systems and processes are effective and cost effective in changing health and social care practitioners' decision-making and ensuring...

    Research recommendation
    Published
    12 October 2015

  12. Ways of providing advocacy services: What is the effectiveness and acceptability of providing advocacy through different approaches?

    details Comes from guidance Advocacy services for adults with health and social care needs Number NG227 Date issued November

    Research recommendation
    Published
    12 December 2022

  13. Individual circumstances and the risk of dependence: Do individual circumstances such as social distress, low income or limited access to alternative sources of support lead to an increased risk of problems associated with dependence on prescribed medicines?

    circumstances and the risk of dependence: Do individual circumstances such as social distress, low income or limited access to...

    Research recommendation
    Published
    11 May 2022

  14. Molnupiravir for treating COVID-19 (TA1056)

    Evidence-based recommendations on molnupiravir (Lagevrio) for treating mild to moderate COVID-19 in adults who have a positive SARS-CoV-2 test.

    Technology appraisal guidance
    Last updated
    26 February 2026

    Sections for TA1056

  15. Spesolimab for treating generalised pustular psoriasis flares (TA1070)

    Evidence-based recommendations on spesolimab (Spevigo) for treating generalised pustular psoriasis flares in adults.

    Technology appraisal guidance
    Published
    18 June 2025
    View recommendations

    Sections for TA1070